BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 78269)

  • 1. Myelofibrosis associated with rubidazone.
    Cheng DS; Eyre HJ
    Lancet; 1978 Jul; 2(8080):104. PubMed ID: 78269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Benzene-associated myelofibrosis at an early stage].
    Uppenkamp M; Meusers P; Donhuijsen K; Brittinger G
    Internist (Berl); 1990 Dec; 31(12):769-72. PubMed ID: 2289867
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diminished bone marrow fibrosis on autopsy in a patient with acute myelofibrosis following chemotherapy].
    Okada K; Ohsaka A; Tsuboyama A; Takeda K; Sasaki R; Kano Y; Sakamoto S; Hirota N; Miura Y
    Rinsho Ketsueki; 1986 Sep; 27(9):1661-7. PubMed ID: 3806976
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical characteristics of primary myelofibrosis].
    Simeonov Ts; Petrov I
    Vutr Boles; 1979; 18(6):108-12. PubMed ID: 524867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelofibrosis with myeloid metaplasia with fatty bone marrow: report of a new case.
    Gerli GC; Gianelli U; Carraro MC; Bestetti A; Marchetti M; Barosi G
    Haematologica; 2001 Aug; 86(8):885-6. PubMed ID: 11524257
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythroid hypoplasia in myelofibrosis: a feature associated with blastic transformation.
    Bentley SA; Murray KH; Lewis SM; Roberts PD
    Br J Haematol; 1977 May; 36(1):41-7. PubMed ID: 871424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on seven patients with acute myelofibrosis].
    Nakayama S; Ishikawa T; Yabe H; Nagai K
    Rinsho Ketsueki; 1987 Aug; 28(8):1345-53. PubMed ID: 3430749
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum procollagen-III-peptide as a marker for primary myelofibrosis: effect of anthracyclin.
    Parmentier C; Schlumberger M; Caillou B; Boaziz C
    Eur J Haematol; 1987 Nov; 39(5):475. PubMed ID: 3480241
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and pathological features of primary myelofibrosis from onset to blast transformation: report of two cases.
    Yonemitsu H; Kanazawa S; Kondo H; Okuda K
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):64-71. PubMed ID: 4003013
    [No Abstract]   [Full Text] [Related]  

  • 10. [Animal experimental production of bone marrow fibroses through continuous injections of ovalbumin in the rabbit].
    Hauswaldt C; Hunstein W; Cohrs U
    Schweiz Med Wochenschr; 1967 Nov; 97(44):1471-2. PubMed ID: 5593690
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic idiopathic myelofibrosis. Study of 36 patients and review of the literature].
    Celada A
    Sangre (Barc); 1983; 28(4):401-20. PubMed ID: 6658634
    [No Abstract]   [Full Text] [Related]  

  • 12. [An autopsy case of acute myelofibrosis with myeloblasts showing hematological remission in the terminal stage].
    Aoyagi Y; Koike ; Terada Y; Kanayama M; Inoue T
    Rinsho Ketsueki; 1986 Oct; 27(10):1874-9. PubMed ID: 3820611
    [No Abstract]   [Full Text] [Related]  

  • 13. [Idiopathic myelofibrosis of childhood. Report of a case and review of the literature (author's transl)].
    Vela Ferrer E; Ferrer-Pi D; Vives Corrons JL; Jou JM; Esteve I; Roldán ML; Barceló J; Cruz Hernández M
    Sangre (Barc); 1981; 26(4):508-14. PubMed ID: 7292231
    [No Abstract]   [Full Text] [Related]  

  • 14. Mast cells and myelofibrosis.
    Udoji WC; Razavi SA
    Am J Clin Pathol; 1975 Feb; 63(2):203-9. PubMed ID: 1115032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on myelofibrosis experimentally induced by saponin (author's transl)].
    Endo H
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):160-71. PubMed ID: 578064
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase 1 and 2 trial of rubidazone in patients with acute leukemia.
    Benjamin RS; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
    Cancer Res; 1977 Dec; 37(12):4623-8. PubMed ID: 270389
    [No Abstract]   [Full Text] [Related]  

  • 17. Idiopathic myelofibrosis. Clinical aspects and studies on extracellular matrix metabolism.
    Hasselbalch HC
    Dan Med Bull; 1993 Mar; 40(1):39-55. PubMed ID: 8472598
    [No Abstract]   [Full Text] [Related]  

  • 18. Marrow fibrosis does not account for circulating CD34+ cells in myelofibrosis with myeloid metaplasia.
    Samuelson SJ; Popat U; Prchal JT
    Haematologica; 2007 Apr; 92(4):e47. PubMed ID: 17405759
    [No Abstract]   [Full Text] [Related]  

  • 19. The pathogenesis of myelofibrosis in myeloproliferative disorders.
    Groopman JE
    Ann Intern Med; 1980 Jun; 92(6):857-8. PubMed ID: 7387029
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.
    Ingle JN; Ahmann DL; O'Fallon JR; Bisel HF; Rubin J; Kvols LK; Giuliani ER
    Cancer Treat Rep; 1979; 63(11-12):1701-5. PubMed ID: 526908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.